Gyre Therapeutics, Inc. · NASDAQ:GYRE
GNI Group Ltd. reported a 69.10% stake in Gyre Therapeutics, Inc. (Schedule 13D/A)
Event May 4, 2026 · Filed May 6, 2026
GNI Group Ltd. reported a 69.10% stake in Gyre Therapeutics, Inc., 86,323,015 shares, with active intent on May 4, 2026. Filed May 6, 2026 (Schedule 13D/A).
- Stake
- 69.10%
- Shares
- 86,323,015
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GNI USA, Inc. | 69.10% | 86,323,015 |
| GNI Group Ltd. | 69.10% | 86,323,015 |